Cargando…
Resistance to Trastuzumab
SIMPLE SUMMARY: Trastuzumab is a humanized antibody that has significantly improved the management and treatment outcomes of patients with cancers that overexpress HER2. Many research groups, both in academia and industry, have contributed towards understanding the various mechanisms engaged by tras...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600208/ https://www.ncbi.nlm.nih.gov/pubmed/36291900 http://dx.doi.org/10.3390/cancers14205115 |